Shares of the Tri-Counties’ newest public company, Arcutis Biotherapeutics, surged 15 percent in the first day of trading after its public debut, following a larger-than-expected IPO that raised nearly $160 million. The Westlake Village biotech company sold some 9.4 million shares of stock, slightly more than it outlined in its registration statement, at $17 each,…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
